Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15503297)

  • 21. Primary renal soft tissue sarcoma in children.
    Tagarelli A; Spreafico F; Ferrari A; Alaggio R; Cecchetto G; Collini P; Indolfi P; Burnelli R; Morali L; Bisogno G
    Urology; 2012 Sep; 80(3):698-702. PubMed ID: 22784490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
    Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group.
    Raney B; Huh W; Hawkins D; Hayes-Jordan A; Million L; Rodeberg D; Teot L; Anderson J;
    Pediatr Blood Cancer; 2013 Mar; 60(3):371-6. PubMed ID: 22961750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.
    Reid EG; Looney D; Maldarelli F; Noy A; Henry D; Aboulafia D; Ramos JC; Sparano J; Ambinder RF; Lee J; Cesarman E; Yahyaei S; Mitsuyasu R; Wachsman W;
    Blood Adv; 2018 Dec; 2(24):3618-3626. PubMed ID: 30573564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical results of high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in children with advanced stage rhabdomyosarcoma.
    Kim NK; Kim HS; Suh CO; Kim HO; Lyu CJ
    J Korean Med Sci; 2012 Sep; 27(9):1066-72. PubMed ID: 22969254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A non-comparative phase II study of dose intensive chemotherapy with doxorubicin and ifosfamide followed by high dose ICE consolidation with PBSCT in non-resectable, high grade, adult type soft tissue sarcomas.
    Hartmann JT; Horger M; Kluba T; Königsrainer A; de Zwart P; von Weyhern CH; Eckert F; Budach W; Bokemeyer C
    Invest New Drugs; 2013 Dec; 31(6):1592-601. PubMed ID: 24091981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group.
    Wagner LM; Fouladi M; Ahmed A; Krailo MD; Weigel B; DuBois SG; Doyle LA; Chen H; Blaney SM
    Pediatr Blood Cancer; 2015 Mar; 62(3):440-4. PubMed ID: 25446280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients].
    Stern N; Sakji I; Defachelles AS; Lervat C; Ryckewaert T; Marliot G; Peugniez C; Deplanque D; Penel N
    Bull Cancer; 2017 Mar; 104(3):208-212. PubMed ID: 27986268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose Chemotherapy Response in Adults with Relapsed/Refractory Small Round Cell Tumours.
    Aykan MB; Erturk I; Acar R; Yildiran GS; Yildiz B; Karadurmus N
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):51-56. PubMed ID: 34983148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replacing actinomycin-D with Carboplatin for newly diagnosed rhabdomyosarcoma.
    Sezgin G; Acipayam C; Bayram I; Ozkan A; Kupeli S; Tanyeli A
    Asian Pac J Cancer Prev; 2015; 16(8):3351-4. PubMed ID: 25921143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.
    Tay T; Somasundaram N; Lim C; Khoo LP; Goh AZK; Lee YS; Liu X; Tao M; Quek R; Farid M; Poon E; Chan JYS; Chang EWY; Yang VSW; Goh YT; Tan D; Diong C; Grigoropoulos NF; Nagarajan C; Poon M; de Mel S; Jeyasekharan A; Chan EHL; Lee J; Chee YL; Lim ST; Tang T
    Cancer Rep (Hoboken); 2022 Sep; 5(9):e1552. PubMed ID: 35481622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
    Strati P; Chihara D; Oki Y; Fayad LE; Fowler N; Nastoupil L; Romaguera JE; Samaniego F; Garg N; Feng L; Wesson ET; Ruben CE; Stafford MD; Nieto Y; Khouri IF; Hosing C; Horowitz SB; Kamble RT; Fanale MA
    Haematologica; 2018 Sep; 103(9):e416-e418. PubMed ID: 29622656
    [No Abstract]   [Full Text] [Related]  

  • 33. Second-line treatment of pediatric patients with relapsed rhabdomyosarcoma adapted to initial risk stratification: Data of the European Soft Tissue Sarcoma Registry (SoTiSaR).
    Heinz AT; Ebinger M; Schönstein A; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter MW; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Rößler J; Ljungman G; Klingebiel T; Koscielniak E; Sparber-Sauer M;
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30363. PubMed ID: 37066598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between tumor response at therapy completion and prognosis in patients with Group III rhabdomyosarcoma: A report from the Children's Oncology Group.
    Lautz TB; Chi YY; Tian J; Gupta AA; Wolden SL; Routh JC; Casey DL; Dasgupta R; Hawkins DS; Rodeberg DA
    Int J Cancer; 2020 Sep; 147(5):1419-1426. PubMed ID: 32012255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults.
    Ju HY; Park M; Lee JA; Park HJ; Park SY; Kim JH; Kang HG; Yang HC; Park BK
    Cancer Res Treat; 2022 Apr; 54(2):563-571. PubMed ID: 34126703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of replacing actinomycin-D with carboplatin in Ewing sarcoma consolidation treatment: Single-center experience.
    Özkan A; Bayram İ; Sezgin G; Mirioğlu A; Küpeli S
    J Bone Oncol; 2022 Aug; 35():100435. PubMed ID: 35664540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study.
    Pappo AS; Vassal G; Crowley JJ; Bolejack V; Hogendoorn PC; Chugh R; Ladanyi M; Grippo JF; Dall G; Staddon AP; Chawla SP; Maki RG; Araujo DM; Geoerger B; Ganjoo K; Marina N; Blay JY; Schuetze SM; Chow WA; Helman LJ
    Cancer; 2014 Aug; 120(16):2448-56. PubMed ID: 24797726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of outcome and prognostic factors in extraosseous Ewing sarcoma.
    Biswas B; Shukla NK; Deo SV; Agarwala S; Sharma DN; Vishnubhatla S; Bakhshi S
    Pediatr Blood Cancer; 2014 Nov; 61(11):1925-31. PubMed ID: 25132242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study.
    Geller JI; Pressey JG; Smith MA; Kudgus RA; Cajaiba M; Reid JM; Hall D; Barkauskas DA; Voss SD; Cho SY; Berg SL; Dome JS; Fox E; Weigel BJ
    Cancer; 2020 Dec; 126(24):5303-5310. PubMed ID: 32914879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma.
    Huang JH; Chen SH; Liao YM; Kao YC; Ho WL; Chang H; Tsai ML; Lee HL; Kuo CC; Tseng SH; Chang CY; Hsieh KL; Lu LS; Chen YJ; Chiou JF; Hsieh TH; Liu YR; Hsu W; Li WT; Wu YC; Wu WC; Wang JL; Tsai JJ; Terashima K; Kiyotani C; Wong TT; Miser JS; Liu YL
    J Pers Med; 2023 Apr; 13(4):. PubMed ID: 37109054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.